Xenon Pharmaceuticals Inc.

NASDAQ:XENE

30.77 (USD) • At close July 30, 2025
Bedrijfsnaam Xenon Pharmaceuticals Inc.
Symbool XENE
Munteenheid USD
Prijs 30.77
Beurswaarde 2,361,092,872
Dividendpercentage 0%
52-weken bereik 26.74 - 46
Industrie Biotechnology
Sector Healthcare
CEO Mr. Ian C. Mortimer C.M.A., CPA, CMA, CPA, M.B.A., MBA
Website https://www.xenon-pharma.com

An error occurred while fetching data.

Over Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopathy; and XEN1101, A Kv7 potassium

Vergelijkbare Aandelen

Travere Therapeutics, Inc. logo

Travere Therapeutics, Inc.

TVTX

15.48 USD

Krystal Biotech, Inc. logo

Krystal Biotech, Inc.

KRYS

153.22 USD

ImmunityBio, Inc. logo

ImmunityBio, Inc.

IBRX

2.56 USD

Establishment Labs Holdings Inc. logo

Establishment Labs Holdings Inc.

ESTA

41.96 USD

Addus HomeCare Corporation logo

Addus HomeCare Corporation

ADUS

107.88 USD

Ligand Pharmaceuticals Incorporated logo

Ligand Pharmaceuticals Incorporated

LGND

135.23 USD

Dynavax Technologies Corporation logo

Dynavax Technologies Corporation

DVAX

11.17 USD

Supernus Pharmaceuticals, Inc. logo

Supernus Pharmaceuticals, Inc.

SUPN

33.56 USD

ModivCare Inc. logo

ModivCare Inc.

MODV

3.04 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)